Efficacy and Safety Study of Lomustine/Temozolomide Combination Therapy vs. Standard Therapy for Glioblastoma Patients (CeTeG)
This study is currently recruiting participants.
Verified July 2012 by University Hospital, Bonn
Sponsor:
University Hospital, Bonn
Information provided by (Responsible Party):
Ulrich Herrlinger, University Hospital, Bonn
ClinicalTrials.gov Identifier:
NCT01149109
First received: June 14, 2010
Last updated: July 31, 2012
Last verified: July 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | February 2015 |
| Estimated Primary Completion Date: | September 2014 (Final data collection date for primary outcome measure) |